Viveve Medical, Inc.
VIVE
$0.0002
$0.000.00%
| 09/30/2022 | 06/30/2022 | 03/31/2022 | 12/31/2021 | 09/30/2021 | |
|---|---|---|---|---|---|
| Revenue | 6.83M | 6.76M | 6.62M | 6.43M | 6.67M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 6.83M | 6.76M | 6.62M | 6.43M | 6.67M |
| Cost of Revenue | 5.71M | 6.07M | 6.06M | 5.81M | 5.76M |
| Gross Profit | 1.12M | 687.00K | 558.00K | 620.00K | 908.00K |
| SG&A Expenses | 13.82M | 13.32M | 12.86M | 12.79M | 12.91M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 27.97M | 28.73M | 28.51M | 27.98M | 26.56M |
| Operating Income | -21.14M | -21.97M | -21.90M | -21.55M | -19.89M |
| Income Before Tax | -22.92M | -23.80M | -22.05M | -21.96M | -20.39M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -22.92 | -23.80 | -22.05 | -21.96 | -20.39 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -68.00K | -68.00K | -68.00K | -68.00K | -60.00K |
| Net Income | -22.99M | -23.87M | -22.12M | -22.03M | -20.45M |
| EBIT | -21.14M | -21.97M | -21.90M | -21.55M | -19.89M |
| EBITDA | -20.34M | -21.09M | -20.90M | -20.43M | -18.68M |
| EPS Basic | -2.65 | -2.72 | -2.54 | -2.67 | -4.65 |
| Normalized Basic EPS | -1.33 | -1.38 | -1.38 | -1.46 | -2.46 |
| EPS Diluted | -2.65 | -2.72 | -2.54 | -2.67 | -4.65 |
| Normalized Diluted EPS | -1.33 | -1.38 | -1.38 | -1.46 | -2.46 |
| Average Basic Shares Outstanding | 42.53M | 42.46M | 42.32M | 40.34M | 31.90M |
| Average Diluted Shares Outstanding | 42.53M | 42.46M | 42.32M | 40.34M | 31.90M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
